HOME >> BIOLOGY >> NEWS
Vion's TAPET Organisms Demonstrate Reduced Virulence, Increased Safety While Retaining Ability To Specifically Target Tumors

Genetically Modified Salmonella Lack Ability to Induce TNF-Alpha and Cause Sepsis According to Nature Biotechnology Publication

NEW HAVEN, CT (December 29, 1998): New research demonstrates that genetic modification of a cell wall component of tumor-targeting Salmonella bacteria can greatly reduce the bacteria's potential for virulence and ability to cause septic shock, announced Vion Pharmaceuticals, Inc. (Nasdaq: VION). Vion is developing the modified bacteria, the heart of the company's TAPET technology, as vectors for the targeted, systemic delivery of anti-cancer agents to tumors throughout the body.

A publication detailing the research, entitled "Lipid A mutant Salmonella with suppressed virulence and TNF-alpha induction retain tumor-targeting in vivo," will appear in the January issue of the journal Nature Biotechnology. The article is authored by scientists at Vion and their collaborators at Yale University School of Medicine; Texas A&M University, College of Veterinary Medicine; and the University of Washington Health Sciences Center.

Vion researchers and their collaborators have previously reported the development of Salmonella that specifically target tumors over normal tissues. However the clinical utility of such bacteria was potentially limited by the ability of lipid A in the bacteria's cell walls to elicit the production of TNF-alpha and trigger septic shock. Now the researchers have shown that a disruption of the Salmonella msbB gene involved in the production of lipid A reduces, by 10,000 fold, the ability of the bacteria's lipid to induce TNF-alpha and cause death in animal models. At the same time, the msbB-minus Salmonella retain their tumor-targeting properties, exhibiting the ability to accumulate in tumors at ratios in excess of 1000:1 compared with normal tissues.

"Administration of these modified bacteria to mice bearing melanoma tumors results in tumors that are less than six percent the size of tumors in unt
'"/>

Contact: Joan Kureczka
JKureczka@aol.com
415-821-2413
Kureczka/Martin Associates
29-Dec-1998


Page: 1 2 3 4

Related biology news :

1. Vions TAPET® administered to first patients in Phase I human intratumoral safety trial at the Cleveland Clinic Foundation
2. Software Helps Decipher Genomes Of Higher Organisms
3. The Fire Down Below: Extreme Heat-Loving Organisms May Be Keys To Molecular Evolution, Origin Of Life, New Book Argues
4. Virginia Tech Scientists To Evaluate Risks Associated With Release of Recombinant Organisms
5. Transposable Elements May Have Had A Major Role In The Evolution Of Higher Organisms
6. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
7. Emory University Scientists Demonstrate New Pathway For Genetic Mutations In Everyday Cell Life
8. Wake Forest Physicians Demonstrate How Gene-Diet Interaction Affects Cholesterol Absorption
9. Ribozyme Pharmaceuticals, Inc. Demonstrates Potent Activity Of A Ribozyme Targeted Against The Hepatitis C Virus
10. Engineering Animation, Inc. Demonstrates Internet Anatomy At Visible Human Project Conference
11. Study Demonstrates High Conservation Potential Of Logged Rainforest

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... Our own cells may be the ... spine. , So comments interventional spine and pain management specialist Jason Arora, DO, who ... or stem cells harvested from a patient’s bone marrow are proving effective therapies for ...
(Date:10/13/2018)... SAN FRANCISCO (PRWEB) , ... October 12, 2018 ... ... addition of Steven Medwell, MD, board certified in colorectal surgery, to its Medical ... world, Dr. Medwell will bring to uBiome his deep expertise in the surgical ...
(Date:10/11/2018)... ... ... Exalto Bearings UK, the manufacturer of high quality rubber-lined cutlass bearings ... Manager. , Cosgrove has over 30 years of experience within the engineering and industrial ... UK facility. , “We are pleased to have Mike join our team,” said Dennis ...
Breaking Biology News(10 mins):
(Date:10/11/2018)... Calif. (PRWEB) , ... October 11, 2018 , ... ... and short-run label printing and software solutions, in collaboration with HP, the global ... certification for Avery UltraDuty GHS Chemical Labels on all HP PageWide Printers. , ...
(Date:10/3/2018)... ... ... Milwaukee Area Technical College (MATC), a public, two-year comprehensive technical college, will ... T129 in the T Building, 101 N. 6th St., to introduce area students, educators, ... formal program will be held at 4 p.m. , MATC recently added new state-of-the ...
(Date:9/29/2018)... ... September 29, 2018 , ... Voxx Analytics announces the immediate ... the power of influence analytics and data-driven engagement decision making. , “For years ... didn’t necessarily have access to the same financial resources as our Top 50 ...
(Date:9/27/2018)... ... September 26, 2018 , ... Medable was named DPharm Idol ... the first human digitome, a digital representation of human health and disease, by ... of all data sources. Dr. Michelle Longmire, Co-Founder and CEO of Medable, explained ...
Breaking Biology Technology:
Cached News: